Metastatic Uveal Melanoma Recruiting Phase 2 Trials for Binimetinib (DB11967)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05170334Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaTreatment